3B Blackbio Dx Limited (NSE:3BBLACKBIO)
1,419.90
-23.40 (-1.62%)
At close: Sep 11, 2026
3B Blackbio Dx Market Cap
3B Blackbio Dx has a market cap or net worth of 12.22 billion as of September 11, 2026. Its market cap has increased by 1.13% in one year.
Market Cap
12.22B
Enterprise Value
11.32B
Revenue
1.53B
Ranking
n/a
PE Ratio
22.01
Stock Price
1,419.90
ChartMarket Cap Chart
Since April 10, 2008, 3B Blackbio Dx's market cap has increased from 100.83M to 12.22B, an increase of 12,020.94%. That is a compound annual growth rate of 29.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 12.22B | 1.52% |
| Dec 31, 2025 | 12.04B | -28.99% |
| Dec 31, 2024 | 16.95B | 150.19% |
| Dec 29, 2023 | 6.78B | 93.81% |
| Dec 30, 2022 | 3.50B | 4.44% |
| Dec 31, 2021 | 3.35B | 26.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 634.28B |
| Anthem Biosciences | 530.70B |
| OneSource Specialty Pharma | 176.77B |
| Concord Biotech | 151.99B |
| Blue Jet Healthcare | 108.89B |
| Supriya Lifescience | 73.84B |
| Zota Health Care | 38.08B |
| Dishman Carbogen Amcis | 26.22B |